Giardia leads to human parasitic disease, and it is highly prevalent in the developing countries.
Introduction

Giardia lamblia (aka; Giardia intestinalis, Giardia doudenalis) is
was the most prevalent parasite with a percentage of >50% of food handlers in Northern Iran.
Many chemotherapeutic agents have been used to treat giardiasis like 5-nitroimidazole and others 8, 9 , but their side effects represent great limitations 10 . Metronidazole is considered a first choice drug, but the issues of toxicity and the emerging parasite resistance are two big concerns 11 . Although the relationship of Metronidazolecancer has not been yet proved to be cause-effect, but the risk is alarming 12, 13 .
Giardia is known to be highly dependents on external sources for lipids [14] [15] [16] and cholesterol [17] [18] . Cholesterol is also important for Giardia encystation 19 . What is more interesting was the finding that the usage of fibrates (Fenofibrate) which is thought to increase bile cholesterol content has resulted in having the giardia being able to colonize the colon Here we are in line with the idea of limiting the amount of cholesterol available to Giardia might be a better option to treat Giardiasis. We 15 . They named it as GILRP. They found that this protein is involved in intracellular lipoprotein uptake.
Materials and Methods
The work was completely achieved in-silico; the materials used are mainly software, webservers and databases. More explanation is to be mentioned in the relevant points.
To find an in-silico evidence for the potential anti-giardia activity of Ezetimibe, we had to search for possible targets. We followed two strategies for finding targets. One strategy was to search for Giardia proteins that are homologous for Ezetimibe's targets in human. We searched for all the possible targets that are known to be acting as Ezetimibe receptors in human. The sequences of these receptors (proteins) were obtained from the NCBI database.
Two Giardia assemblages; assemblage A and assemblage B is known to infect human. PSI-BLAST 32 was employed to search for the Giardia homologs of these proteins in these assemblages. The scoring matrix set to BLOSUM50 and the remaining parameters as default.
The second strategy was to search in the literature for protein that is known to be involved in cholesterol uptake.
Models prediction, refinement and assessment
The protein sequences in FASTA format were retrieved from the employs discrete molecular dynamics simulation to resolve steric clashes was used for models' refinement. For GL113565, we did also topology prediction using TOPCONS 36 .
Docking
Docking was performed using the molecular modeling suite; Sybyl-x 2.1.1. The docking mode was set to Surflex-Dock GeomX. The binding sites were based on research findings in the literature as well as prediction. For LCAT, amino acids predicted by I-TASSER to be probably involved in binding sites were used for the docking of Ezetimibe.
For GILPR, researchers 15 have identified two possible regions in the protein to be as the binding sites R1 (Amino acids 134 to 151) and R2 (Amino acids 178 to 200). We used them in addition to those predicted by I-TASSER. We have used these amino acids residues to generate the protomol; which is a specified space for docking i.e. binding site 37 .
Results
Previous research found that four human proteins 25, 26, 30, 31, 38) 
Discussion
Generally, it is widely acknowledged that 3D models for target proteins of ≤ 30% sequence identities (Twilight zone)to the template are not highly reliable and do not qualify for further studies like docking. But I-TASSER predicted models for twilight zone proteins have recently been found to produce docking results similar to those produced when using crystallographic structure 39 . Moreover, TMScore of the two models is above 0.5 which means the predicted models have similar folds to those in the PDB 40, 41 .
The refinement of the models through energy minimization resulted in fair improvement of the overall quality of the models.
The topology of GILPR indicates that this protein has one transmembrane which is in agreement with the general topology of LRP (Low density lipoprotein receptor-related proteins) as predicted by M. R. Rivero 42 . But at the same time it is not in agreement with the tertiary structure model predicted by I-TASSER. This shows that this protein needs more research to fully be characterized.
Many binding sites were investigated for docking Ezetimibe as shown in table 2 and table 3 
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